ANPC News and Press, AnPac Bio-Medical Science Co. Ltd. From 04/06/23

AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering PR Newswire NEW YORK , April 6, 2023 /PRNewswire/-- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and ...

AnPac Bio-Medical Science (NASDAQ: ANPC) , a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food...

2023-04-03 11:22:50 ET AnPac Bio-Medical Science ( NASDAQ: ANPC ) said that on March 31 it signed an agreement with Easy Hundred to acquire certain fixed assets of Easy Hundred and Easy Hundred's intellectual property (IP) relating to ez100, 2Supply and 100WAY. The IP inclu...

AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc. PR Newswire NEW YORK , April 3, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and ...

2023-04-03 05:25:35 ET AnPac Bio-Medical Science ( NASDAQ: ANPC ) priced its registered direct offering of its American Depositary Shares (ADSs) and warrants to raise ~$3M in gross proceeds. Under an agreement with certain institutional investors, the company will se...

New York, NY, March 31, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-busine...

2023-03-31 10:05:49 ET Gainers: Y-mAbs Therapeutics ( YMAB ) +43% . G Medical Innovations ( GMVD ) +41% . Palisade Bio ( PALI ) +20% . Inozyme Pharma ( INZY ) +17% . Paratek Pharmaceuticals ( PRTK ) +17% . Losers: Pyxis...

AnPac Bio-Medical Science (NASDAQ: ANPC) , a company with operations in the United States and China focused on early cancer screening and detection and with plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian-source...

AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023 PR Newswire NEW YORK , March 23, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC...

AnPac Bio-Medical Science (NASDAQ: ANPC) , a company with operations in the United States and China focused on early cancer screening and detection, received the first payment in late February 2023 from a Malaysian customer that had purchased AnPac Bio’s Model...